companydata.dkcompanydata.dk

GK PHARMA ApS: Financial statements 2020

CVR: 81267316

Source: annual report 2020, Danish Business Authority

01/01/2020 – 31/12/2020

GK PHARMA ApS (CVR 81267316) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 13,992,642 and a net result of DKK 1,384,796 compared with DKK 712,177 the year before. That is an increase of 45.3% compared with the year before. The profit margin was 9.9%. Equity in the 2020 report amounted to DKK 1,584,796. The solvency ratio was 26.2%.

Revenue
DKK 13,992,642
Gross Profit
DKK 4,559,941
Profit/Loss
DKK 1,384,796
Equity
DKK 1,584,796
Total Assets
DKK 6,053,301

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
202014 mio.4.6 mio.1.4 mio.1.6 mio.-
20199.6 mio.3.3 mio.712 t.912 t.-
20189 mio.3.2 mio.308 t.508 t.-
20178.8 mio.3.3 mio.436 t.200 t.-
20167.5 mio.2.7 mio.113 t.-236 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is GK PHARMA ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

GK PHARMA ApS: The 2019 annual report is outJul 2, 2020

GK PHARMA ApS has published its annual report for 2019. Revenue came to DKK 9,631,011, and the net result was DKK 712,177.

About GK PHARMA ApS

GK PHARMA ApS is a Danish company of the type Anpartsselskab based in Køge, founded in 1977. The company is registered under the industry Fremstilling af parfume, hårshampoo, tandpasta mv.. The management consists of Klaus Groth. The board consists of Dorthe Groth (chair) and Klaus Groth. The company is owned by Salvefabrikken ApS. The company has 10 employees (2018). In 2025, the company reported a gross profit of DKK 5,931,212 and a net result of DKK 2,646,889 compared with DKK 954,244 the year before. Equity in the 2025 report amounted to DKK 4,029,041.

Source: annual report 2025, Danish Business Authority